Evidence map›Paper›PMID 30599855›Full record

ArticleEuropean journal of radiology2019

Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer.

Eric Kim, Eralda Mema, Deborah Axelrod, Eric Sigmund, Sungheon Gene Kim, James Babb, Amy N Melsaether

Abstract read
In one paragraph

Article in European journal of radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Eric KimDepartment of Radiology, NYU School of Medicine, New York, NY, USA. Electronic address: Eric.Kim2@nyumc.org.
Eralda MemaDepartment of Radiology, NYU School of Medicine, New York, NY, USA. Electronic address: Eralda.mema@nyumc.org.
Deborah AxelrodDepartment of Surgery, Perlmutter Cancer Center, NYU School of Medicine, New York, NY, USA. Electronic address: Deborah.axelrod@nyumc.org.
Eric SigmundBernard and Irene Schwartz Center for Biomedical Imaging, Department of Radiology, NYU School of Medicine, New York, NY, USA. Electronic address: PhDEric.Sigmund@nyumc.org.
Sungheon Gene KimBernard and Irene Schwartz Center for Biomedical Imaging, Department of Radiology, NYU School of Medicine, New York, NY, USA. Electronic address: Gene.Kim@nyumc.org.
James BabbBernard and Irene Schwartz Center for Biomedical Imaging, Department of Radiology, NYU School of Medicine, New York, NY, USA. Electronic address: James.Babb@nyumc.org.
Amy N MelsaetherDepartment of Radiology, NYU School of Medicine, New York, NY, USA. Electronic address: amy.melsaether@mountsinai.org.
New York University · USNYU Langone’s Laura and Isaac Perlmutter Cancer Center

Funding

TR&D 4: Revealing Microstructure: Biophysical modeling and validation for discovery and clinical careP41EB017183 · NIBIB · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Christopher M Collins · 2014 to 2026
$19.3M
DCE MRI Study for Breast Cancer.R01CA160620 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI KIM, SUNGHEON GENE · 2012 to 2023
$5.4M
Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast CancerR01CA219964 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI KIM, SUNGHEON GENE, MOY, LINDA · 2018 to 2022
$2.3M
NCI NIH HHS R01 CA160620NCI NIH HHS R01 CA219964NIBIB NIH HHS P41 EB017183
6 · The paper itself

Abstract

purposeTo investigate how breast parenchymal uptake (BPU) of 18F-FDG on positron emission tomography/ magnetic resonance imaging (PET/MRI) in patients with breast cancer is related to background parenchymal enhancement (BPE), amount of fibroglandular tissue (FGT), and age, as well as whether BPU varies as a function of distance from the primary breast cancer. MATERIALS AND

methodsIn this institutional review board (IRB)-approved retrospective study, 40 patients (all female, ages 32-80 years, mean 52 years) gave informed consent prior to undergoing contrast enhanced breast PET/MRI from 3/2015 to 2/2018. Of the 40 patients, 6 were excluded for multicentric or bilateral cancers, 1 for current lactation and 6 because the raw data from their scans were corrupted. The remaining 27 patients (all female, ages 33 to 80 years, mean age 53 years) comprised the study population. Prone PET and contrast-enhanced MR data were acquired simultaneously on a 3-T integrated PET/ MR system. BPU was measured as SUVmax of a 1.5 cm

resultsBPU was significantly greater in the same quadrant as the breast cancer as compared with the opposite quadrant of the same breast (p < 0.001 for both readers) and was significantly greater in the opposite quadrant of the same breast compared to the matched quadrant of the contralateral breast (p = 0.002 for reader 1 and <0.001 for reader 2). While the FGT SUVmax in the same quadrant as the cancer correlated significantly with SUVmax of the index lesion, the FGT SUVmax in the opposite quadrant of the same breast and in the matched quadrant of the contralateral breast did not. The FGT SUVmax in the contralateral breast positively correlated with the degree of BPE and negatively correlated with age, but did not show a significant correlation with the amount of FGT for either reader.

conclusionThere appears to be an inverse correlation between metabolic activity of normal breast parenchyma and distance from the index cancer. BPU significantly correlates with BPE.

Indexed as

AdultAgedAged, 80 and overBreastBreast NeoplasmsFemaleFluorodeoxyglucose F18HumansMagnetic Resonance ImagingMiddle AgedMultimodal ImagingPositron-Emission TomographyRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18RadiopharmaceuticalsBackground parenchymal uptakeBPEBPUBreastPET background parenchymal enhancement

Identifiers

PMID30599855
PMCPMC6472913
OpenAlexW2903481348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.